Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Augmenting L-Theanine in the Management of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

NCT00372151 is registered in ClinicalTrials.gov with Sha'ar Menashe Mental Health Center as lead sponsor.

NCT NCT00372151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00372151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Augmenting L-Theanine in the Management of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Lead sponsor
Sha'ar Menashe Mental Health Center
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2006
Completion date
December 31, 2008
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia